Springer Protocols: Abstract: Animal Models of Spontaneous Autoimmune Disease: Type 1 Diabetes in the Nonobese Diabetic Mouse

Animal Models of Spontaneous Autoimmune Disease: Type 1 Diabetes in the Nonobese Diabetic Mouse

By: Nadia Giarratana², Giuseppe Penna², Luciano Adorini²

Abstract

Full Text

Download PDF (228K)

The nonobese diabetic (NOD) mouse represents probably the best spontaneous model for a human autoimmune disease. It has provided not only essential information on type 1 diabetes (T1D) pathogenesis, but also valuable insights into mechanisms of immunoregulation and tolerance. Importantly, it allows testing of immunointervention strategies potentially applicable to man. The fact that T1D incidence in the NOD mouse is sensitive to environmental conditions, and responds, sometimes dramatically, to immunomanipulation, does not represent a limit of the model, but is likely to render it even more similar to its human counterpart. In both cases, macrophages, dendritic cells, CD4⁺, CD8⁺, and B cells are present in the diseased islets. T1D is a polygenic disease, but, both in human and in NOD mouse T1D, the primary susceptibility gene is located within the MHC. On the other hand, T1D incidence is significantly higher in NOD females, although insulitis is similar in both sexes, whereas in humans, T1D occurs with about equal frequency in males and females. In addition, NOD mice have a more widespread autoimmune disorder, which is not the case in the majority of human T1D cases. Despite these differences, the NOD mouse remains the most representative model of human T1D, with similarities also in the putative target autoantigens, including glutamic acid decarboxylase IA-2, and insulin.

Affiliation(s): (2) BioXell, Milan, Italy

Book Title: Immunological Tolerance: Methods and Protocols

Series: Methods in Molecular Biology | Volume: 380 | Pub. Date: Jun-08-2007 | Page Range: 285-311 | DOI: 10.1007/978-1-59745-395-0_17

Subject: Immunology

Key Words: Autoimmunity - type 1 diabetes - NOD mouse - tolerance - immunoregulation

References

Download References

1.	Bach, J.-F. (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev. 15, 516–542.

2.	Adorini, L., Gregori, S., and Harrison, L. (2002) Understanding autoimmune diabetes: insights from mouse models. Trends Mol. Med. 8, 31–38.

3.	Kikutani, H. and Makino, S. (1992) The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol. 51, 285–322.

4.	Serreze, D. V., Gaedeke, J. W., and Leiter, E. H. (1993) Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc. Natl. Acad. Sci. USA 90, 9625–9629.

5.	Kataoka, S., Satoh, J., Fujiya, H., et al. (1983) Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32, 247–253.

6.	Ogasawara, K., Hamerman, J. A., Hsin, H., et al. (2003) Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity 18, 41–51.

7.	Naumov, Y. N., Bahjat, K. S., Gausling, R., et al. (2001) Activation of CD1 d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA 98, 13,838–13,843.

8.	Wang, Geng, Y. and Wang, R. (2001) CD 1-restricted NK T cells protect nonobese diabetic mice from developing diabetes. J. Exp. Med. 194, 313–320.

9.	Salomon, B., Lenschow, D. J., Rhee, L., et al. (2000) B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12, 431–440.

10.	Gregori, S., Giarratana, N., Smiroldo, S., and Adorini, L. (2003) Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171, 4040–4047.

11.	Baxter, A. G. and Cooke, A. (1993) Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 42, 1574–1578.

12.	Makino, S., Kunimoto, K., Muraoka, Y., Mizushima, Y., Katagiri, K., and Tochino, Y. (1980) Breeding of a non-obese, diabetic stain of mice. Exp. Animal 29, 1–13.

13.	Pozzilli, P., Signore, A., Williams, A. J., and Beales, P. E. (1993) NOD mouse colonies around the world: recent facts and figures. Immunol. Today 14, 193–196.

14.	Andre, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C., and Mathis, D. (1996) Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl. Acad. Sci. USA 93, 2260–2263.

15.	Yoon, J. W. (1990) The role of viruses and environmental factors in the induction of diabetes. Curr. Top. Microbiol. Immunol. 164, 95–123.

16.	Yoon, J. W. (1992) Induction and prevention of type 1 diabetes mellitus by viruses. Diabete Metab. 18, 378–386.

17.	Davydova, B., Harkonen, T., Kaialainen, S., Hovi, T., Vaarala, O., and Roivainen, M. (2003) Coxsackievirus immunization delays onset of diabetes in non-obese diabetic mice. J. Med. Virol. 69, 510–520.

18.	Bach, J. F. (2005) Infections and autoimmune diseases. J. Autoimmun. 25, 74–80.

19.	Williams, A. J., Krug, J., Lampeter, E. F., et al. (1990) Raised temperature reduces the incidence of diabetes in the NOD mouse. Diabetologia 33, 635–637.

20.	Like, A. A. and Rossini, A.A. (1976) Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus. Science 193, 415–417.

21.	Malaisse, W. J. (1982) Alloxan toxicity to the pancreatic B cell. A new hypothesis. Biochem. Pharmacol. 31, 3527–3534.

22.	Kolb, H. and Kroencke, K.-D. (1993) IDDM. Lessons from the low-dose streptozocin model in mice. Diabetes Rev. 1, 116–126.

23.	Cossel, L., Schneider, E., Kuttler B, et al. (1985) Low dose streptozotocin induced diabetes in mice. Metabolic, light microscopical, histochemical, immunofluorescence microscopical, electron microscopical and morphometrical findings. Exp. Clin. Endocrinol. 85, 7–26.

24.	Gerling, I. C., Friedman, H., Greiner, D. L., Shultz, L. D., and Leiter, E.H. (1994) Multiple low-dose streptozocin-induced diabetes in NOD-scid/scid mice in the absence of functional lymphocytes. Diabetes 43, 433–440.

25.	Harada, M. and Makino, S. (1984) Promotion of spontaneous diabetes in nonobese diabetes-prone mice by cyclophosphamide. Diabetologia 27, 604–606.

26.	Kay, T. W., Campbell, I. L., and Harrison, L. (1991) Characterization of pancreatic T lymphocytes associated with beta cell destruction in the non-obese diabetic (NOD) mouse. J. Autoimmun. 4, 263–276.

27.	Yasunami, R. and Bach, J.-F. (1988) Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18, 481–484.

28.	Christianson, S. W., Shultz, L. D., and Leiter, E. H. (1993) Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4⁺ and CD8⁺ T-cells from diabetic versus prediabetic NOD.NON-Thy-1^a donors. Diabetes 42, 44–55.

29.	Wicker, L. S., Miller, B. J., and Mullen, Y. (1986) Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 35, 855–860.

30.	Bendelac, A., Carnaud, C., Boitard, C., and Bach, J.-F. (1987) Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4⁺ and Lyt-2⁺ T cells. J. Exp. Med. 166, 823–832.

31.	Wong, F. S., Visintin, I., Wen, L., Flavell, R. A., and Janeway, A., Jr. (1996) CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J. Exp. Med. 183, 67–76.

32.	Haskins, K. and Wegmann, D. (1996) Diabetogenic T-cell clones. Diabetes 45, 1299–1305.

33.	Chatenoud, L., Thervet, E., Primo, J., and Bach, J.F. (1994) Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 91, 123–127.

34.	Wang, B., Gonzales, A., Benoist, C., and Mathis, D. (1996) The role of CD8⁺ cells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 26, 1762–1769.

35.	Shizuru, J. A., Taylor-Edwards, C., Banks, B. A., Gregory, A. K., and Fathman, G. (1988) Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T-helper lymphocytes. Science 240, 659–662.

36.	Kurasawa, K., Sakamoto, A., Maeda, T., et al. (1993) Short-term administration of anti-L3T4 MoAb prevents diabetes in NOD mice. Clin. Exp. Immunol. 91, 376–380.

37.	Mori, Y., Suko, M., Okudaira, H., et al. (1986) Preventive effects of cyclosporin on diabetes in NOD mice. Diabetologia 29, 244–247.

38.	Serreze, D. V., Fleming, S. A., Chapman, H. D., Richard, S. D., Leiter, E. H., and Tisch, R. M. (1998) B lymphocytes are critical antigen-presenting cells for the initiation of T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Immunol. 161, 3912–3918.

39.	Wicker, L., Todd, J., and Peterson, L. (1995) Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13, 179–200.

40.	Falcone, M. and Sarvetnick, N. (1999) Cytokines that regulate autoimmune responses. Curr. Opin. Immunol. 11, 670–676.

41.	Balasa, B., A. La Cava, K. Van Gunst, L., et al. (2000) A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes. J. Immunol. 165, 7330.

42.	Kawamoto, S., Nitta, Y., Tashiro, F., et al. (2001) Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10. Int. Immunol. 13, 685–694.

43.	Green, E. A., Eynon, E. E., and Flavell, R.A. (1998) Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 9, 733–743.

44.	Grewal, I. S., Grewal, K. D., Wong, F. S., Picarella, D. E., Janeway A., Jr.,and Flavell, R.A. (1996) Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells. J. Exp. Med. 184, 1963–1974.

45.	Wong, S., Guerder, S., Visintin, I., et al. (1995) Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouse. Diabetes 44, 326–329.

46.	Lenschow, D. J., Herold, K. C., Rhee, L., et al. (1996) CD28/B7 regulation of TH1 and TH2 subsets in the development of autoimmune diabetes. Immunity 5, 285–293.

47.	Hulbert, C., Riseili, B., Rojas, M., and Thomas, J. (2001) B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J. Immunol. 167, 5535–5538.

48.	Petrovsky, N., Silva, D., Socha, L., Slattery, R., and Charlton, B. (2002) The role of Fas ligand in beta cell destruction in autoimmune diabetes of NOD mice. Ann. NYAcad. Sci. 958, 204–208.

49.	Savinov, A., Tcherepanov, A., Green, E., Flavell, R., and Chervonsky, A. (2003) Contribution of Fas to diabetes development. Proc. Natl. Acad. Sci. USA 100, 628–632.

50.	Sung, H., Juang, J., Lin, Y., et al. (2004) Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J. Exp. Med. 199, 1143–1151.

51.	Katz, J., Benoist, C., and Mathis, D. (1993) Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23, 3358–3360.

52.	Wicker, L. S., Leiter, E. H., Todd, J.A., et al. (1994) Beta 2-microglobulindeficient NOD mice do not develop insulitis or diabetes. Diabetes 43, 500–504.

53.	Mora, C., Wong, F. S., Chang, H., and Flavell, R.A. (1999) Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice. J. Immunol. 162, 4576–4588.

54.	Kay, T. W. H., Parker, J. L., Stephens, L. A., Thomas, H. E., and Allison, J. (1996) RIP-b2-microglobulin transgene expression restores insulitis, but not diabetes, in b₂-microglobulin^null nonobese diabetic mice. J. Immunol. 157, 3688–3693.

55.	Trembleau, S., Germann, T., Gately, M. K., and Adorini, L. (1995) The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol. Today 16, 383–386.

56.	Trembleau, S., Penna, G., Gregori, S., et al. (1999) Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J. Immunol. 163, 2960–2968.

57.	Trembleau, S., Penna, G., Gregori, S., Giarratana, N., and Adorini, L. (2003) IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-inducedIFN-gamma. J. Immunol. 170, 5491–5501.

58.	Balasa, B., Van Gunst, K., Jung, N., Katz, J. D., and Sarvetnick, N. (2000) IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse. Cell. Immunol. 202, 97–102.

59.	Wang, B., Gonzalez, A., Hoglund, P., Katz, J. D., Benoist, C., and Mathis, D. (1998) Interleukin-4 deficiency does not exacerbate disease in NOD mice. Diabetes 47, 1207–1211.

60.	Falcone, M., Yeung, B., Tucker, L., Rodriguez, E., Krahl, T., and Sarvetnick, N. (2001) IL-4 triggers autoimmune diabetes by increasing self-antigen presentation within the pancreatic Islets. Clin. Immunol. 98, 190–199.

61.	Green, E. A., Wong, F. S., Eshima, Mora, and Flavell, R. A. (2000) Neonatal tumor necrosis factor alpha promotes diabetes in nonobese diabetic mice by CD154-independent antigen presentation to CD8(+) T cells. J. Exp. Med. 191, 225–238.

62.	Martin, S., van den Engel, N., Vinke, A., Heidenthal, E., Schulte, B., and Kolb, H. (2001) Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. J. Autoimmun. 17, 109.

63.	Anderson, M. S., Venanzi, E. S., Chen, Z., Berzins, S. P., Benoist, C., and Mathis, D. (2005) The cellular mechanism of Aire control of T cell tolerance. Immunity 23, 227–239.

64.	Villasenor, J., Benoist, C., and Mathis, D. (2005) AIRE and APECED: molecular insights into an autoimmune disease. Immunol. Rev. 204, 156–164.

65.	Lohmann, T., Leslie, R. D., and Londei, M. (1996) T cell clones to epitopes of glutamic acid decarboxylase 65 raised from normal subjects and patients with insulin-dependent diabetes. J. Autoimmun. 9, 385–389.

66.	Semana, G., Gausling, R., Jackson, R. A., and Hafler, D. A. (1999) T cell autore-activity to proinsulin epitopes in diabetic patients and healthy subjects. J. Autoimmun. 12, 259–267.

67.	Miyazaki, T., Uno, M., Uehira, M., et al. (1990) Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice. Nature 345, 722–724.

68.	Nishimoto, H., Kikutani, H., Yamamura, K. L, and Kishimoto, T. (1987) Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice. Nature 328, 432–434.

69.	Uehira, M., Onu, M., Miyazaki, J., Nishimoto, H., Kishimoto, T., and Yamamura, K. (1989) Development of autoimmune insulitis is prevented in E alpha d but not in A beta k NOD transgenic mice. Int. Immunol. 1, 209–213.

70.	Lund, T., O’Reilly, L., Hutchings, P., et al. (1990) Prevention of insulin-dependent diabetes in non-obese diabetic mice by transgenes encoding modified I-A b-chain or normal I-E a-chain. Nature 345, 727–729.

71.	Boehme, J., Schuhbaur, B., Kanagawa, O., Benoist, C., and Mathis, D. (1990) MHC-linked protection from diabetes dissociated from clonal deletion of T cells. Science 249, 293–295.

72.	Trembleau, S., Gregori, S., Penna, G., Gorny, I., and Adorini, L. (2001) IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule. J. Immunol. 167, 4104–4114.

73.	Schmidt, D., Amrani, A., Verdaguer, J., Bou, S., and Santamaria, P. (1999) Autoantigen-independent deletion of diabetogenic CD4+ thymocytes by protective MHC class II molecules. J. Immunol. 162, 4627–4636.

74.	Carrasco-Marin, E., Shimizu, J., Kanagawa, O., and Unanue, E. (1996) The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders. J. Immunol. 156, 450–458.

75.	Ridgway, W. M. and Fathman, C. G. (1999) MHC structure and autoimmune T cell repertoire development. Curr. Opin. Immunol. 11, 638–642.

76.	Harrison, L. C., Honeyman, M. C., Trembleau, S., et al. (1997) A peptide-binding motif for I-Ag7, the class II MHC molecule of NOD and Biozzi AB/H mice. J. Exp. Med. 185, 1013–1021.

77.	Corper, A. L., Stratmann, T., Apostolopoulos, V., et al. (2000) A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 288, 505–511.

78.	French, M., Allison, J., Cram, D. S., et al. (1997) Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46, 34–39.

79.	Wong, F. S., Karttunen, J., Dumont, C., et al. (1999) Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat. Med. 5, 1026–1031.

80.	Yoon, J. W., Yoon, S., Lim, H. W., et al. (1999) Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284, 1183–1187.

81.	Ranheim, E. A., Tarbell, K., Krogsgaard, M., et al. (2004) Selection of aberrant class II restricted CD8+ T cells in NOD mice expressing a glutamic acid decarboxylase (GAD)65-specific T cell receptor transgene. Autoimmunity 37, 555–567.

82.	Trembleau, S., Penna, G., Gregori, S., Magistrelli, G., Isacchi, A., and Adorini, L. (2000) Early Th1 response in unprimed nonobese diabetic mice to the tyrosine phosphatase-like insulinoma-associated protein 2, an autoantigen in type 1 diabetes. J. Immunol. 165, 6748–6755.

83.	Trembleau, S., Penna, G., Bosi, E., Mortara, A., Gately, M.K., and Adorini, L. (1995) IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181, 817–821.